Filter articles using the following links

KOL Call on LUMEVOQ® for the Treatment of Leber Hereditary Optic Neuropathy (LHON)

BIO 2020, San Diego (CA), US – Digital

2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled

ASGCT 23rd Annual Meeting, Boston (MA), USA – Virtual Format

GenSight Biologics will hold its General Meeting on April 29, 2020 behind closed doors

2020 AAN Annual Meeting, Toronto, Canada – canceled due to COVID-19

GenSight Biologics Reports Cash Position as of March 31, 2020 and Provides Operational Update

GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA

GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa

H.C. Wainwright Global Life Sciences Conference, London, UK – cancelled